author

 
 

Meta

Chris Kay
For Chris Kay's latest contributions to The Japan Times, see below:
Japan Times
BUSINESS
Jun 1, 2023
Contaminated drugs, shredded papers: U.S. FDA uncovers failures in India pharma factories
Authorities have suspended the licenses of more than a dozen unlisted drugmakers in the wake of dozens of cough syrup deaths.
Japan Times
ASIA PACIFIC
Apr 14, 2023
A fresh, but mild, COVID wave is rippling through Asia
Singapore’s infections almost doubled in the final week of March to the highest rate this year, data from the Ministry of Health showed.
Japan Times
BUSINESS
Nov 14, 2022
Asia's richest man challenges China in show of support for Modi
With Sri Lanka in the throes of its worst economic crisis since independence, India is re-engaging and attempting to tilt the balance in a strategic tussle with China.
Japan Times
ASIA PACIFIC / Science & Health / FOCUS
Aug 9, 2022
Monkeypox cases driven 'underground' by anti-gay stigma in India
In parts of the world where LGBTQ people face stigma and bias, patients are reluctant to seek testing or treatment for a disease that has recently afflicted gay and bisexual men.
Japan Times
WORLD / Science & Health
Apr 12, 2022
India hopes ‘Pharma City’ will break China’s grip on industry
Itu2019s a vast project that shows how governments are growing increasingly concerned about Chinau2019s stranglehold over drug supplies u2014 as well as the challenges they face in loosening it.
Japan Times
WORLD
Mar 29, 2022
World moves from shortages to possible glut of COVID-19 vaccines
Even as boosters are likely to keep demand alive for COVID-19 inoculations worldwide, the desperate shortages that existed for much of last year have waned.
Japan Times
ASIA PACIFIC
Dec 29, 2021
How errors and inaction sent a deadly COVID-19 variant around the world
In early 2021, flare-ups in the Indian city of Amravati were the first visible warning that the delta variant was spreading. A devastating path across the world would soon follow.
Japan Times
ASIA PACIFIC
Jul 21, 2021
A secretive body is making questionable COVID-19 decisions in India
As the Indian Council of Medical Research has acted as a key adviser to the government, it has drawn criticism from doctors and independent scientists.
Japan Times
WORLD
Jun 9, 2021
Biggest vaccine-maker’s problems keep world short of COVID-19 shots
The Serum Institute of India's travails have become a key illustration of how the effort to inoculate against COVID-19 has failed the developing world.
Japan Times
WORLD
Apr 28, 2021
As India reels, vaccine hoarding could backfire on rich nations
There is a growing realization that vaccine nationalism has the potential to ultimately prolong the pandemic.
Japan Times
WORLD
Apr 16, 2021
COVID-19 is more deadly in Brazil than India, and no one knows why
Why the Latin American country has been far more devastated by the pathogen is baffling experts.
Japan Times
WORLD / Science & Health
Mar 20, 2021
Vaccine nationalism threatens WHO’s 2021 goal of 2 billion doses
Concerns are being raised that countries are holding tight to their supplies and restricting access to materials needed to make more.
EDITORIALS
Jun 10, 2011
Scrutinizing Fukushima crisis
The government on Tuesday released a report on the accidents at Fukushima No.1 nuclear power plant. Submitted to the International Atomic Energy Agency, the report describes 28 lessons and countermeasures.

Longform

At the Akan International Crane Center, just north of the city of Kushiro proper, visitors can see the majestic red-crowned crane — a symbol of Hokkaido.
Faces of the north: A Hokkaido town grapples with depopulation